SAMDaily.us | AWARD | A | Central Laboratory for Pharmacokinetic/Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception

SAMDAILY.US - ISSUE OF MARCH 20, 2021 SAM #7051
AWARD

A -- Central Laboratory for Pharmacokinetic/Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception

Notice Date: 3/18/2021 4:13:04 PM
Notice Type: Award Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: NATIONAL INSTITUTES OF HEALTH NICHD BETHESDA MD 20817 USA
ZIP Code: 20817
Solicitation Number: None
Archive Date: 04/17/2021
Award Number: 75N94020D00016
Award Date: 02/09/2021
Awardee: OREGON HEALTH & SCIENCE UNIVERSITY Portland OR USA
Award Amount: 120567.00
Description: The authority waiving the competition requirements is FAR 16.505(b)(2)(i)(B), only one awardee is capable of providing the supplies or services required at the level of quality required because the supplies or services ordered are unique or highly specialized.� Oregon Health & Science University was the central lab for the initial clinical trial. Use of the same central lab is necessary for continuity, comparability, and integrity of the results.
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/26923534074e425c9859d16941709b2e/view)
Place of Performance: Address: Portland, OR 97239, USA; Zip Code: 97239; Country: USA
Record: SN05946159-F 20210320/210318230104 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |